Targeting MYC dependence in cancer by inhibiting BET bromodomains.
Ontology highlight
ABSTRACT: The MYC transcription factor is a master regulator of diverse cellular functions and has been long considered a compelling therapeutic target because of its role in a range of human malignancies. However, pharmacologic inhibition of MYC function has proven challenging because of both the diverse mechanisms driving its aberrant expression and the challenge of disrupting protein-DNA interactions. Here, we demonstrate the rapid and potent abrogation of MYC gene transcription by representative small molecule inhibitors of the BET family of chromatin adaptors. MYC transcriptional suppression was observed in the context of the natural, chromosomally translocated, and amplified gene locus. Inhibition of BET bromodomain-promoter interactions and subsequent reduction of MYC transcript and protein l
SUBMITTER: Mertz JA
PROVIDER: S-EPMC3189078 | biostudies-literature | 2011 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA